These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12163813)

  • 1. Skin necrosis after extravasation of low-dose vasopressin administered for septic shock.
    Kahn JM; Kress JP; Hall JB
    Crit Care Med; 2002 Aug; 30(8):1899-901. PubMed ID: 12163813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin necrosis after a low-dose vasopressin infusion through a central venous catheter for treating septic shock.
    Kim EH; Lee SH; Byun SW; Kang HS; Koo DH; Park HG; Hong SB
    Korean J Intern Med; 2006 Dec; 21(4):287-90. PubMed ID: 17249516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral administration of vasopressin for catecholamine-resistant hypotension complicated by skin necrosis.
    Bunker N; Higgins D
    Crit Care Med; 2006 Mar; 34(3):935; author reply 935-6. PubMed ID: 16505698
    [No Abstract]   [Full Text] [Related]  

  • 4. Vasopressin versus norepinephrine infusion in patients with septic shock.
    Russell JA; Walley KR; Singer J; Gordon AC; Hébert PC; Cooper DJ; Holmes CL; Mehta S; Granton JT; Storms MM; Cook DJ; Presneill JJ; Ayers D;
    N Engl J Med; 2008 Feb; 358(9):877-87. PubMed ID: 18305265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of continuous vasopressin infusion in patients with septic shock.
    Obritsch MD; Jung R; Fish DN; MacLaren R
    Ann Pharmacother; 2004; 38(7-8):1117-22. PubMed ID: 15178740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose vasopressin infusion can be an alternative in treating patients with refractory septic shock combined with chronic pulmonary hypertension--a case report.
    Wang HJ; Wong CS; Chiang CY; Yeh CC; Cherng CH; Ho ST; Wu CT
    Acta Anaesthesiol Sin; 2003 Jun; 41(2):77-80. PubMed ID: 12934421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local cutaneous necrosis secondary to a prolonged peripheral infusion of methylene blue in vasodilatory shock.
    Dumbarton TC; Gorman SK; Minor S; Loubani O; White F; Green R
    Ann Pharmacother; 2012 Mar; 46(3):e6. PubMed ID: 22388329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Push-Dose Vasopressin for Hypotension in Septic Shock.
    Nowadly CD; Catlin JR; Fontenette RW
    J Emerg Med; 2020 Feb; 58(2):313-316. PubMed ID: 32173168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasopressin: A tool as rescue therapy? Take care of dosages and adverse effects!
    Angstwurm M
    Crit Care Med; 2005 Nov; 33(11):2713-4. PubMed ID: 16276218
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypotension Risk Based on Vasoactive Agent Discontinuation Order in Patients in the Recovery Phase of Septic Shock.
    Sacha GL; Lam SW; Duggal A; Torbic H; Reddy AJ; Bauer SR
    Pharmacotherapy; 2018 Mar; 38(3):319-326. PubMed ID: 29328496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Body Weight on Hemodynamic Response in Patients Receiving Fixed-Dose Vasopressin for Septic Shock.
    Hodge EK; Hughes DW; Attridge RL
    Ann Pharmacother; 2016 Oct; 50(10):816-23. PubMed ID: 27340145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock.
    Tsuneyoshi I; Yamada H; Kakihana Y; Nakamura M; Nakano Y; Boyle WA
    Crit Care Med; 2001 Mar; 29(3):487-93. PubMed ID: 11373409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and Design of an Adaptive Phase 2b/3 Clinical Trial of Selepressin for Adults in Septic Shock. Selepressin Evaluation Programme for Sepsis-induced Shock-Adaptive Clinical Trial.
    Lewis RJ; Angus DC; Laterre PF; Kjølbye AL; van der Meulen E; Blemings A; Graves T; Russell JA; Carlsen JE; Jacobsen K; Yealy DM; Opal SM; Windeløv NA; François B; Perner A; Pickkers P; Berry SM
    Ann Am Thorac Soc; 2018 Feb; 15(2):250-257. PubMed ID: 29388815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anesthetic management using vasopressin for a patient complicated with septic shock].
    Matsuno Y; Saito K; Hirabayashi Y; Seo N
    Masui; 2006 Nov; 55(11):1398-400. PubMed ID: 17131893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does body weight impact the efficacy of vasopressin therapy in the management of septic shock?
    Miller JT; Welage LS; Kraft MD; Alaniz C
    J Crit Care; 2012 Jun; 27(3):289-93. PubMed ID: 21855282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Outcomes After Vasopressin Guideline Implementation in Septic Shock.
    Wu JY; Stollings JL; Wheeler AP; Semler MW; Rice TW
    Ann Pharmacother; 2017 Jan; 51(1):13-20. PubMed ID: 27630192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long-term survival rate of catecholamine-resistant septic shock in Japanese patients who received vasopressin therapy.
    Sawa N; Ubara Y; Katori H; Hoshino J; Suwabe T; Takemoto F; Uchida N; Masuoka K; Wake A; Taniguchi S; Takaichi K
    Clin Nephrol; 2009 Aug; 72(2):129-36. PubMed ID: 19640370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical review: Vasopressin and terlipressin in septic shock patients.
    Delmas A; Leone M; Rousseau S; Albanèse J; Martin C
    Crit Care; 2005 Apr; 9(2):212-22. PubMed ID: 15774080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasopressin Plasma Concentrations Are Not Associated with Hemodynamic Response to Exogenous Vasopressin for Septic Shock.
    Yerke JR; Sacha GL; Scheraga RG; Culver DA; Abraham S; Torbic H; Lam SW; Ammar MA; Olman MA; Bauer SR
    Pharmacotherapy; 2020 Jan; 40(1):33-39. PubMed ID: 31705703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series.
    Holmes CL; Walley KR; Chittock DR; Lehman T; Russell JA
    Intensive Care Med; 2001 Aug; 27(8):1416-21. PubMed ID: 11511958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.